Analysis of LPAR3 also demonstrated significantly increased expression in HCC vs. NTL (Figure 1C, IHC score 1.13 ± 0.12 vs. 0.28 ± 0.05, HCC vs. NTL, *p < 0.001). This evidence concerns the gene LPAR3 and hepatocellular carcinoma.